Home Amines 1228875-13-5
1228875-13-5,MFCD17976841
Catalog No.:AA000JLE

1228875-13-5 | (4-Fluorotetrahydro-2h-pyran-4-yl)methanamine hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
≥95%
2 weeks  
$185.00   $130.00
- +
250mg
≥95%
2 weeks  
$336.00   $235.00
- +
1g
≥95%
2 weeks  
$1,147.00   $803.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000JLE
Chemical Name:
(4-Fluorotetrahydro-2h-pyran-4-yl)methanamine hydrochloride
CAS Number:
1228875-13-5
Molecular Formula:
C6H12FNO
Molecular Weight:
133.1640
MDL Number:
MFCD17976841
SMILES:
NCC1(F)CCOCC1
Properties
Computed Properties
 
Complexity:
91.1  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
-0.1  

Downstream Synthesis Route
406233-31-6    1228875-13-5   
4-(((4-fluorotetrahydro-2H-pyran-4-yl)methyl)amino)-3-nitrobenzenesulfonamide 

[1]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC-WO2021/173523,2021,A1Locationinpatent:Page/Pagecolumn183

[2]CurrentPatentAssignee:RECURIUMIPHOLDINGSLLC-WO2019/139902,2019,A1Locationinpatent:Paragraph0438

[3]CurrentPatentAssignee:RECURIUMIPHOLDINGSLLC-WO2021/7303,2021,A1Locationinpatent:Paragraph0346

[4]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2Locationinpatent:Page/Pagecolumn102

[5]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1Locationinpatent:Paragraph0624;0625

[1]CurrentPatentAssignee:ABBVIEINC-WO2013/134085,2013,A1

[2]CurrentPatentAssignee:ABBVIEINC-US2014/57927,2014,A1

[3]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2

[4]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1

[5]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC;GUANGZHOULUPENGPHARMACEUTICALLTD-WO2021/66873,2021,A1

[6]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC-WO2021/173523,2021,A1

[1]CurrentPatentAssignee:ABBVIEINC-WO2013/134085,2013,A1

[2]CurrentPatentAssignee:ABBVIEINC-US2014/57927,2014,A1

[3]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2

[4]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1

[5]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC;GUANGZHOULUPENGPHARMACEUTICALLTD-WO2021/66873,2021,A1

[6]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC-WO2021/173523,2021,A1

[1]CurrentPatentAssignee:ABBVIEINC-WO2013/134085,2013,A1

[2]CurrentPatentAssignee:ABBVIEINC-US2014/57927,2014,A1

[3]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2

[4]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1

[5]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC;GUANGZHOULUPENGPHARMACEUTICALLTD-WO2021/66873,2021,A1

[6]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC-WO2021/173523,2021,A1

[1]CurrentPatentAssignee:ABBVIEINC-WO2013/134085,2013,A1

[2]CurrentPatentAssignee:ABBVIEINC-US2014/57927,2014,A1

[3]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2

[4]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1

[5]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC;GUANGZHOULUPENGPHARMACEUTICALLTD-WO2021/66873,2021,A1

[6]CurrentPatentAssignee:NEWAVEPHARMACEUTICALINC-WO2021/173523,2021,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1228875-13-5 Molecular Formula|1228875-13-5 MDL|1228875-13-5 SMILES|1228875-13-5 (4-Fluorotetrahydro-2h-pyran-4-yl)methanamine hydrochloride